Evidence map›Paper›PMID 40207784›Full record

ReviewChemistry (Weinheim an der Bergstrasse, Germany)2025

Fused Nitrogen Bridgehead N,O-Acetals as Versatile Scaffolds: Synthetic Strategies, Mechanism and Applications.

Alexis D Kouvelas, Michael G Kallitsakis, Ioannis N Lykakis

Abstract readReview
In one paragraph

Review in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexis D KouvelasDepartment of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece.
Michael G KallitsakisDepartment of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece.
Ioannis N LykakisDepartment of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece.ORCID https://orcid.org/0000-0001-8165-5604

Funding

An Open-Access Research Infrastructure of Chemical Biology and Target-Based Screening Technologies for Human and Animal Health, Agriculture and the Environment (OPENSCREEN-GR) 5002691Reinforcement of the Research and Innovation Infrastructure 2014-2020
6 · The paper itself

Abstract

Fused Bicyclic N,O-acetals, are prominently present in several natural products and constitute a versatile family of compounds, with nitrogen-bridgehead fused N,O-bicyclic derivatives receiving specific emphasis as pivotal scaffolds due to their significant role in the bioactivity of medicinally relevant molecules. Hence, significant advancements in their applications in Organic Synthesis have been extensively documented in the literature, highlighting their role as key synthetic building blocks/motifs in the construction of complex organic molecules and their utility as chiral auxiliaries in the enantioselective synthesis of natural products and synthetic compound libraries. Nonetheless, while these developments have been well-explored, our review offers a new perspective by consolidating and critically evaluating various synthetic strategies for accessing the nitrogen-bridgehead fused N,O-acetal frameworks (such as hydropyrrolo-oxazole and oxazine frameworks) providing new insights into their mechanistic approaches and applications, and demonstrating their full potential in advanced synthetic chemistry. These methodologies are systematically covered in terms of their mechanistic pathways, synthetic efficiency, and practical applications, providing an integrated understanding of their contribution to the field of Organic Synthesis.

Indexed as

fused bicyclesheterocyclesnitrogen bridgeheadN,O‐acetalsorganic synthesis

Identifiers

PMID40207784
PMCPMC12144904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.